Cargando…

Long-term Persistent Elite HIV-controllers: The Right Model of Functional Cure

Detalles Bibliográficos
Autores principales:	Tarancon-Diez, Laura, Dominguez-Molina, Beatriz, Viciana, Pompeyo, Lopez-Cortes, Luis, Ruiz-Mateos, Ezequiel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835553/ https://www.ncbi.nlm.nih.gov/pubmed/29361500 http://dx.doi.org/10.1016/j.ebiom.2018.01.013

Ejemplares similares

Persistent HIV‐controllers are more prone to spontaneously clear HCV: a retrospective cohort study
por: Dominguez‐Molina, Beatriz, et al.
Publicado: (2020)

Immune Correlates of Natural HIV Elite Control and Simultaneous HCV Clearance—Supercontrollers
por: Dominguez-Molina, Beatriz, et al.
Publicado: (2018)

Immunometabolism is a key factor for the persistent spontaneous elite control of HIV-1 infection
por: Tarancon-Diez, Laura, et al.
Publicado: (2019)

Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure
por: Casado, Concepcion, et al.
Publicado: (2020)

HIV persistence in the CNS: the final frontier for a cure?
por: Lewin, Sharon R, et al.
Publicado: (2016)

Antiretroviral Treatment for HIV Elite Controllers?
por: Ruiz-Mateos, Ezequiel, et al.
Publicado: (2020)

The many faces of HIV elite control
por: Tiemessen, Caroline T.
Publicado: (2021)

Differential Effects of Viremia and Microbial Translocation on Immune Activation in HIV-Infected Patients Throughout Ritonavir-Boosted Darunavir Monotherapy
por: BenMarzouk-Hidalgo, Omar J., et al.
Publicado: (2015)

Absolute CD4(+) T cell count overstate immune recovery assessed by CD4(+)/CD8(+) ratio in HIV-infected patients on treatment
por: Milanés-Guisado, Yusnelkis, et al.
Publicado: (2018)

Following the elite: Targeting immunometabolism to limit HIV pathogenesis
por: Routy, Jean-Pierre, et al.
Publicado: (2019)

HIV “cure”: A shot in the arm?
por: Peluso, Michael J., et al.
Publicado: (2019)

High-resolution anoscopy in HIV-infected men: Assessment of the learning curve and factors that improve the performance
por: Neukam, Karin, et al.
Publicado: (2019)

Finding a cure for HIV: will it ever be achievable?
por: Lewin, Sharon R, et al.
Publicado: (2011)

HIV Infection of Macrophages: Implications for Pathogenesis and Cure
por: Clayton, Kiera L., et al.
Publicado: (2017)

Multifarious immunotherapeutic approaches to cure HIV-1 infection
por: Imami, Nesrina, et al.
Publicado: (2015)

No difference in effectiveness of treatment simplification to boosted or unboosted atazanavir plus lamivudine in virologically suppressed in HIV-1-infected patients
por: Gutierrez-Valencia, Alicia, et al.
Publicado: (2018)

How Much HIV is Alive? The Challenge of Measuring Replication Competent HIV for HIV Cure Research
por: Ananworanich, Jintanat, et al.
Publicado: (2015)

Polyfunctional HIV-1 specific response by CD8+ T lymphocytes expressing high levels of CD300a
por: Vitallé, Joana, et al.
Publicado: (2020)

Mesenchymal stromal cells in human immunodeficiency virus‐infected patients with discordant immune response: Early results of a phase I/II clinical trial
por: Trujillo‐Rodríguez, María, et al.
Publicado: (2020)

Modeling HIV persistence and cure studies
por: Hill, Alison L.
Publicado: (2018)

Role of APOBEC3H in the Viral Control of HIV Elite Controller Patients
por: Benito, José M., et al.
Publicado: (2018)

Elites can take care of themselves — Comment on COVID-19: the rude awakening for the political elite in low-income and middle-income countries
por: Torres, Irene, et al.
Publicado: (2020)

A Cure for HIV Infection: “Not in My Lifetime” or “Just Around the Corner”?
por: Lederman, Michael M., et al.
Publicado: (2016)

Viral reservoirs in elite controllers of HIV-1 infection: Implications for HIV cure strategies
por: Woldemeskel, Bezawit A., et al.
Publicado: (2020)

HCV Viral Decline at Week 2 of Peg-IFN-Alpha-2a/RBV Therapy as a Predictive Tool for Tailoring Treatment in HIV/HCV Genotype 1 Co-Infected Patients
por: Rivero-Juarez, Antonio, et al.
Publicado: (2014)

Increased CD127+ and decreased CD57+ T cell expression levels in HIV-infected patients on NRTI-sparing regimens
por: Gonzalez-Serna, A., et al.
Publicado: (2017)

Darunavir/cobicistat showing similar effectiveness as darunavir/ritonavir monotherapy despite lower trough concentrations
por: Gutierrez‐Valencia, Alicia, et al.
Publicado: (2018)

Will LEDGIN molecules be able to play a role in a cure for HIV infection?
por: Mesplède, Thibault, et al.
Publicado: (2016)

Towards an HIV cure: science and debate from the International AIDS Society 2013 symposium
por: Purcell, Damian FJ, et al.
Publicado: (2013)

Towards the next step: LoViRet patients for HIV-1 cure studies
por: Crespo, Raquel, et al.
Publicado: (2020)

Influence of IL28B Polymorphisms on Response to a Lower-Than-Standard Dose peg-IFN-α 2a for Genotype 3 Chronic Hepatitis C in HIV-Coinfected Patients
por: López-Cortés, Luis F., et al.
Publicado: (2012)

Prevalence and resistance mutations of non-B HIV-1 subtypes among immigrants in Southern Spain along the decade 2000-2010
por: de Felipe, Beatriz, et al.
Publicado: (2011)

Does Once-Daily Raltegravir Have Any Role in the Antiretroviral Treatment?
por: Gutierrez-Valencia, Alicia, et al.
Publicado: (2015)

What the elite athlete does not want to know
por: Sengkerij, P., et al.
Publicado: (2018)

Insights from Clonal Expansion and HIV Persistence in Perinatal Infections
por: Dhummakupt, Adit, et al.
Publicado: (2021)

Evolution of Serum Acute-Phase Glycoproteins Assessed by (1)H-NMR in HIV Elite Controllers
por: Malo, Ana-Irene, et al.
Publicado: (2021)

Immunoescape of HIV-1 in Env-EL9 CD8 + T cell response restricted by HLA-B*14:02 in a Non progressor who lost twenty-seven years of HIV-1 control
por: Moyano, Ana, et al.
Publicado: (2022)

Improved CD4 T cell profile in HIV-infected subjects on maraviroc-containing therapy is associated with better responsiveness to HBV vaccination
por: Herrero-Fernández, Inés, et al.
Publicado: (2018)

Long-term survivors with immunotherapy in advanced NSCLC: is ‘cure’ within reach?
por: Monteverdi, Sara, et al.
Publicado: (2020)

High frequency of CD8 escape mutations in elite controllers as new obstacle for HIV cure
por: Navarrete-Muñoz, María A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cfij0g13ung4et9uaom9jhh5ko